Metcalf et al.26 have noted a 48% reduction of death from breast cancer in BRCA1/2 mutation carriers who undergo contralateral RRM compared to those who undergo ipsilateral mastectomy after a 20-year follow-up. Here, BRCA1 is linked to breast carcinoma.